...
首页> 外文期刊>American Journal of Case Reports >Thrombolysis in Postoperative Pulmonary Embolism Following Liver Transplantation: A Case Report
【24h】

Thrombolysis in Postoperative Pulmonary Embolism Following Liver Transplantation: A Case Report

机译:肝移植后术后肺栓塞溶栓:案例报告

获取原文
           

摘要

Patient: Male, 55-year-old Final Diagnosis: Sever pulmonary embolism after liver transplantation Symptoms: Sudden shortness of breath in the second post operative day Medication: Anticoagulant Clinical Procedure: Liver transplantation Specialty: Transplantology Objective: Unusual or unexpected effect of treatment Background: Postoperative pulmonary embolism following liver transplantations is still one of the most fatal complications, especially during the early postoperative phase. The use of a thrombolytic agent such as the recombinant tissue-type plasminogen activator (rtPA) is considered a contraindication early after major abdominal surgery such as liver transplantation. However, thrombolysis after major surgery in the early postoperative period carries a substantial risk of surgical site hemorrhage. Case Report: A 55-year-old patient presented with a hepatic mass diagnosed as a combined cholangio/hepatocellular carcinoma. Following the criteria of the University of San Francisco, California (UCSF) for liver transplantation, the case was selected for liver transplantation. The patient received neoadjuvant therapy. After the liver transplantation, on the second postoperative day, an acute, severe dyspnea with sudden onset occurred on the surgical ward. A computed tomography angiography showed a drawn-out embolus, which sprawled into both pulmonary main arteries and occluded them subtotally. A thrombolysis with rtPA was started. Within the first 60 minutes of administration of rtPA, the circulation stabilized effectively, so that epinephrine could be tapered down to zero and the patient was promptly extubated. About 6 hours after administration of rtPA, a sudden and pronounced bleeding via one of the intraperitoneal drains occurred, hemoglobin concentration dropped from 9.7 g/dL to 6.4 g/dL. After immediate re-laparotomy, circulation and hemoglobin concentration were absolutely stable. Conclusions: Even with anticipated high risk of bleeding, thrombolysis with rtPA can be used as a life-savings treatment in a case of pulmonary embolism after liver transplantation.
机译:患者:男性,55岁的最终诊断:肝移植后的肺栓塞症状:突然呼吸急性缺血性日药药物:抗凝剂临床手术:肝移植专业:移植学特理:治疗方法:治疗背景不寻常或意外效果:肝移植后术后肺栓塞仍然是最致命的并发症之一,特别是在术后期初期间。使用溶栓剂如重组组织型纤溶酶原激活剂(RTPA)被认为是在主要腹部手术如肝移植之后的早期禁忌症。然而,术后早期手术后重大手术后的溶栓会带来手术部位出血的大量风险。案例报告:一个55岁的患者呈现肝脏肿块,被诊断为胆管/肝细胞癌。遵循旧金山大学,加利福尼亚州(UCSF)进行肝移植,选择肝移植的情况。患者接受了Neoadjuvant治疗。在肝移植后,在第二次术后一天,在手术病房上发生突然发作的急性严重呼吸困难。计算的断层造影血管造影显示出拉出的栓子,其蔓延至两种肺部主动脉并无表闭塞。开始溶栓栓塞。在rtpa施用的前60分钟内,循环有效稳定,使肾上腺素可以逐渐变为零,患者迅速拔下。在施用RTPA后约6小时,通过其中一个腹膜内排水突然和明显的出血,血红蛋白浓度从9.7g / d1降至6.4g / dl。在立即重新剖腹产术后,循环和血红蛋白浓度绝对稳定。结论:即使预期出血风险高,肝脏移植后的肺栓塞的情况下,rtpa的溶栓也可用作挽救寿命治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号